Search Results

• • 9 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Facile synthesis of bromelain copper nanoparticles to improve the primordial therapeutic potential of copper against acute myocardial infarction in diabetic rats.

  Authors:Megha Sahu, Arun K. Sharma, Gunjan Sharma, Ashish Kumar, Mukesh Nandave, and Varsha BabuFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 20225,607 words Report 1380L

   Citation Only

• Effect of soya phosphatidylcholine and possible underlying mechanism on ischemia/reperfusion injury in isolated perfused rat heart: an experimental and computational study.

  Authors:Anita A. Mehta, Purav Patel, Vandana R. Thakur, and Jayesh V. BeladiyaFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 20224,079 words Report 1390L

   Citation Only

• Introduction to IACS India.

  From:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 2022755 words Conference notes 1320L

   Citation Only

• Inhibition of endoplasmic reticulum stress combined with activation of angiotensin-converting enzyme 2: novel approach for the prevention of endothelial dysfunction in type 1 diabetic rats.

  Authors:Himanshu Sankrityayan, Ajinath Kale, and Anil Bhanudas GaikwadFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 20225,077 words Report 1310L

   Citation Only

• Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia.

  Authors:Vivek Bora, Dhwani Patel, Kaid Johar, Ramesh K. Goyal, and Bhoomika M. PatelFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 20228,948 words Report 1480L

   Citation Only

• Cannabinoid 2 receptor agonist and L-arginine combination attenuates diabetic cardiomyopathy in rats via NF-[kappa][beta] inhibition.

  Authors:Vivek S. Kumawat and Ginpreet KaurFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 20227,527 words Report 1430L

   Citation Only

• Therapeutic enzymes as non-conventional targets in cardiovascular impairments: A comprehensive review.

  Authors:Gaurav Kumar, Manisha Saini, and Suman KunduFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 202212,653 words Report 1490L

   Citation Only

• Nanoparticle-eluting stents for coronary intervention: formulation, characterization, and in vitro evaluation.

  Authors:Ankit A. Agrawal, Ankur J. Raval, Shilpa M. Velhal, Vainav V. Patel, and Vandana B. PatravaleFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 20228,269 words Report 1440L

   Citation Only

• Effect of parthenolide, an NLRP3 inflammasome inhibitor, on insulin resistance in high-fat diet-obese mice.

  Authors:Pavan Kumar Chinta, Suhas Tambe, Dhananjay Umrani, Ajay Kumar Pal, and Mukesh NandaveFrom:Canadian Journal of Physiology and Pharmacology (Vol. 100, Issue 3) Peer-Reviewed

  Mar. 20227,256 words Report 1510L

   Citation Only